MING HSIAO: Open Payments
NPI 1588096127 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,758 in 84 payments from 8 companies in 2025. Trend: 2023 $15,457 · 2024 $15,376 · 2025 $13,758
Speaker / faculty: $8,098Travel & lodging: $3,567Food & beverage: $2,038Education: $55
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 55 | $12,932 |
| Merck Sharp & Dohme LLC | 8 | $284 |
| United Therapeutics Corporation | 9 | $216 |
| Kestra Medical Technology Services, Inc. | 2 | $204 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $49 |
| Abbott Laboratories | 1 | $35 |
| PFIZER INC. | 1 | $21 |
| Medtronic, Inc. | 1 | $18 |
Products named: UPTRAVI, WINREVAIR, Assure WCD, OPSYNVI, Remodulin, OPSUMIT, LifeVest, CARDIOMEMS.
Industry payments across WA — which companies pay providers there.
